Loading company…
Phil Rivers Technology develops AI platforms and drug research programs for pharmaceutical development.
Founded in 2015 and based in Beijing, Phil Rivers Technology focuses on AI-powered pharmaceutical research and development. Its platforms support biomedical knowledge, virtual clinical trials, and quantitative assessment of cell function, with research programs in pancreatic, liver, and breast cancer. In August 2026, it raised nearly CNY 200 million in a Series A2 round to advance its AI platforms and drug development programs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in